Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aya R. Ahmed"'
Publikováno v:
BMC Chemistry, Vol 17, Iss 1, Pp 1-11 (2023)
Abstract The work introduces green and white sustainable micellar electrokinetic chromatography (MEKC) procedure that could analyze therapeutically related drugs, empagliflozin (EMP), linagliptin (LIN) and metformin (MET) which are antidiabetic drugs
Externí odkaz:
https://doaj.org/article/545f4d8c06c5402b9295bfdbc6de7d8a
Publikováno v:
Sustainable Chemistry and Pharmacy. 33:101066
Publikováno v:
Chemical Papers. 73:1209-1219
Valsartan (VAL) can be analyzed at the mercury electrode in the presence of nickel (II) yielding a sensitive cathodic peak at − 0.7 V which may be attributed to the reduction of the complex formed between nickel and VAL. Low LOD and LOQ were achiev
Publikováno v:
Journal of Chromatographic Science. 56:498-509
Valsartan (VAL) and sacubitril (SAC) are combined in a supramolecular complex, LCZ696, which is a newly approved remedy for heart failure. SAC-related substance (biphenyl methyl pyrrolidinone [BMP]) which also appears as an intermediate during SAC sy
Publikováno v:
Luminescence. 32:1417-1425
LCZ696 (sacubitril/valsartan, Entresto™) is a therapy lately approved by United States Food and Drug Administration (US FDA) as a heart failure therapy. It is claimed to decrease the mortality rate and hospitalization for patients with chronic hear
Publikováno v:
Bioanalysis. 11(2)
Aim: Differential pulse polarography was used for the concurrent analysis of the coadministered dantrolene (DAN) and indomethacin (IND) in plasma. Materials & methods: DAN and IND, Hanging mercury drop electrode and Britton–Robinson buffer at pH 5
A newly FDA-approved heart failure therapy (LCZ696, supramolecular complex of sacubitril (SAC) and valsartan (VAL), Entresto™) is analyzed with a stability indicating HPLC–DAD method. For the newly introduced drug, SAC, there is no sufficient inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb73db4502c390ae0bd4fa8ae3f6605c